Company Profile

Cibus Global LLC (AKA: Cibus Genetics LLC)
Profile last edited on: 7/10/18      CAGE: 62PQ2      UEI:

Business Identifier: Precision gene editing, generally, and advanced non-transgenic breeding
Year Founded
2001
First Award
2004
Latest Award
2012
Program Status
Inactive
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

6455 Nancy Ridge Drive Suite 100
San Diego, CA 92121
   (858) 450-0008
   info@cibusllc.com
   www.cibus.com
Location: Single
Congr. District: 52
County: San Diego

Public Profile

Formerly dba Cibus Genetics LLC., Cibus Global has developed plant and microbial platforms offering precision gene editing and advanced non-transgenic breeding. The firm's proprietary technology - Rapid Trait Development System (RTDS™) - supports non-transgenic breeding, enabling site-specific edits of native genes with no introduction of foreign DNA. The precise and predictable outcomes can replicate products developed using traditional mutagenesis and, with time, are identical to those that could occur in nature. Consequently, these plants are not considered transgenic, the key attributes of GMO crops. Cibus has launched its first commercial crop, SU Canola™, a non-transgenic canola tolerant to sulfonylurea herbicides in the United States, and has received regulatory approval in Canada. Cibus expects to develop new, non-transgenic traits for most major crops. Cibus is the parent company of Nucelis -- focused on the cosmetic, nutraceutical and lubricant additive segments through its RTDS-based yeast production process (ypRTDS) to make squalane: a squalane process and product is both GMO-free and sustainable. The ypRTDS™ platform offers a wide variety of additional specialty chemical applications. Nucelis is built on Cibus’ platform of unique, patented technology for optimizing cell structure and function. Nucelis’ vision is to change the way industry develops bio-based chemicals by utilizing nature’s own production factories such as plants, yeast, and

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
100-149
Revenue Range
10M-15M
VC funded?
Yes
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2012 1 USDA $99,980
Project Title: Disease Tolerance in the Solanaceae
2004 1 USDA $80,000
Project Title: Eliminating Preharvest Dehiscence in Canola Using Genoplasty Technology

Key People / Management

  Keith Walker -- Chief Executive Officer and President

  Peter Beetham -- Senior Vice President, Research & Development

  Greg Gocal -- Vice President, Research

  Sean O'Connor -- Senior Vice President

  James Radtke -- Vice President, Product Development

  David Voss -- Vice President, Commercial Development